Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 2 1

Status

Completed 20Unknown 5Recruiting 2Withdrawn 1Active not recruiting 1

Sponsor Class

OTHER 5

Study Type

Interventional 3Observational 2

Sponsor

Cancer Type

Classical hematology 5Breast 3Gynecologic 2

Conditions

Neoplasms 23Venous Thromboembolism 20Febrile Neutropenia 20Anemia 20Thrombocytopenia 15Myelodysplastic Syndromes 14Leukemia, Myeloid, Acute 14Lymphoma 12Leukemia 12Anemia, Refractory, with Excess of Blasts 10Anemia, Aplastic 10Colorectal Neoplasms 9Breast Neoplasms 8Anemia, Iron-Deficiency 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Anemia, Sickle Cell 7Neutropenia 6Multiple Myeloma 6Ovarian Neoplasms 5Neoplasms, Plasma Cell 5Lymphoma, Follicular 5Hematologic Neoplasms 5Fanconi Anemia, Complementation Group D1 5Hemophilia A 4Chemotherapy-induced Thrombocytopenia 4Stroke 3Pulmonary Disease, Chronic Obstructive 3Parkinson Disease 3Osteoporosis 3Multiple Sclerosis 3

Interventions

Trabectedin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Unknown × Fanconi Anemia, Complementation Group D1 × Classical hematology × Clear all
NCT02959398 2017-11-24

ETOLE

Assistance Publique - Hôpitaux de Paris

Phase NA Unknown
2,000 enrolled
BreastClassical hematology

Fanconi Anemia, Complementation Group D1, Breast Neoplasms

NCT00413491 2014-05-20

MR BRCA

Danish Breast Cancer Cooperative Group

Phase 4 Unknown
300 enrolled
BreastClassical hematology

Fanconi Anemia, Complementation Group D1, Breast Neoplasms

NCT01772979 2013-01-21

MITO15

Catholic University of the Sacred Heart

Phase 2 Unknown
100 enrolled
Classical hematologyGynecologic

Fanconi Anemia, Complementation Group D1, Ovarian Neoplasms

NCT00509509 2012-05-24

High Risk Breast Cancer Screening Program

Organisation for Oncology and Translational Research

Unknown
BreastClassical hematology

Breast Cancer, Familial, Fanconi Anemia, Complementation Group D1, Breast Neoplasms

NCT00155896 2005-09-12

Establishing the Incidences of BRCA1 and BRCA2 Mutation by Combining DHPLC and Direct Sequencing in Ovarian Cancer

National Taiwan University Hospital

Unknown
100 enrolled
Classical hematologyGynecologic

Fanconi Anemia, Complementation Group D1, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡